title: Female-initiated barrier methods for the prevention of STI/HIV: where are we now? Where should we go?
abstract: The female condom has been on the US market for over 8 years and was hailed as a method that would allow women greater control in protecting themselves against unwanted pregnancy and sexually transmitted infections. However, since its launch, promotion of the female condom has met with challenges that vary from provider bias against the device, concerns about efficacy, and doubts about whether it will be used. While daunting, many of these challenges are not unique to the female condom. In fact, they parallel those of the tampon when it was first promoted in the US for menstrual hygiene in the early 1930s. Many providers were initially opposed to the tampon; early users found the tampon inadequate. Ten years after the introduction of the tampon and despite mass marketing, acceptability was mixed and use was modest (25% prevalence in a 26-city survey). Similar to female condom use observed in current-day prospective studies, users did not use the tampon exclusively or even predominantly. The story of the tampon demonstrates that a method does not have to be adopted by all users immediately to play an important role, and that even initially controversial methods can become widely accepted as mainstream. The early history of the tampon sheds perspective, and hope, on where we stand with the female condom. While much-needed work is under way to develop microbicides, we should take advantage of the fact that the female condom is already available and promote it to those in need now.
authors.affiliation: Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, Room 556, New York, NY 10029, USA. Mlatka@nyam.org
authors.forename: M
authors.initials: M
authors.lastname: Latka
mesh_terms: D000329:Advertising; D001294:Attitude to Health; D019111:Single-Use Internal Condom / Q000706:statistics & numerical data*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D021841:Safe Sex / Q000523:psychology*; D020377:Self Efficacy; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D014481:United States; D016387:Women's Health